BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3602444)

  • 1. The incidence of long-term side effects--in particular induced leukemias following treatment for Hodgkin's disease.
    De Renzis C; Cellini N; Ausili Cefaro GP; Mantini G; Parisi S; Smaniotto D
    Rays; 1986; 11(2):109-13. PubMed ID: 3602444
    [No Abstract]   [Full Text] [Related]  

  • 2. [Acute leukemia in patients treated for Hodgkin's disease].
    Boccaccio P; Rosa F; Casciaro S; D'Elia P; Romagnoli M; Ghio R
    Recenti Prog Med; 1988 Jan; 79(1):32-7. PubMed ID: 3375542
    [No Abstract]   [Full Text] [Related]  

  • 3. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second neoplasms in Hodgkin's disease: current controversies.
    Zarrabi MH; Rosner F
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):303-18. PubMed ID: 2663829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute non-lymphatic leukemia after treatment of Hodgkin's lymphoma with chemotherapy and radiotherapy].
    Lira P; Grebe G
    Rev Med Chil; 1984 Oct; 112(10):1021-5. PubMed ID: 6085597
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute myeloid leukemia following therapy of Hodgkin's disease with radiotherapy and ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine).
    Lipton JH; Gospodarowicz M; Reingold S
    Hematol Oncol; 1996 Mar; 14(1):29-31. PubMed ID: 8613133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of erythrocyte mean corpuscular volume during cytotoxic therapy as a predictive parameter of the risk of secondary leukemia in Hodgkin's disease.
    de Gramont A; Rioux E; Drolet Y; Delage JM
    Cancer Treat Rep; 1984 Dec; 68(12):1467-70. PubMed ID: 6509452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease.
    Henry-Amar M
    J Natl Cancer Inst; 1983 Nov; 71(5):911-6. PubMed ID: 6580491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute non-lymphoblastic leukosis as a second neoplasm in Hodgkin's disease].
    Díaz Pérez MA; Zamora Auñón P; Escobar Alvarez Y; García de Parecdes ML
    Med Clin (Barc); 1985 Feb; 84(4):167. PubMed ID: 3982119
    [No Abstract]   [Full Text] [Related]  

  • 10. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease.
    N Engl J Med; 1987 Sep; 317(11):707-9. PubMed ID: 3627177
    [No Abstract]   [Full Text] [Related]  

  • 11. Hodgkin's disease: long-term effects of therapy.
    Rowland KM; Murthy A
    Med Pediatr Oncol; 1986; 14(2):88-96. PubMed ID: 3520268
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute leukemia after the treatment of Hodgkin's disease.
    Henry-Amar M; Dietrich PY
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):369-87. PubMed ID: 8468271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemia and other cancers after radiotherapy and chemotherapy for Hodgkin's disease.
    Boivin JF; Hutchison GB
    J Natl Cancer Inst; 1981 Oct; 67(4):751-60. PubMed ID: 6944544
    [No Abstract]   [Full Text] [Related]  

  • 14. Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
    Valagussa P; Bonadonna G
    Haematologica; 1998 Sep; 83(9):769-70. PubMed ID: 9825571
    [No Abstract]   [Full Text] [Related]  

  • 15. Second primary cancers following treatment of Hodgkin's disease.
    Boivin JF; Hutchison GB; Lyden M; Godbold J; Chorosh J; Schottenfeld D
    J Natl Cancer Inst; 1984 Feb; 72(2):233-41. PubMed ID: 6420598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followup.
    Coltman CA; Dixon DO
    Cancer Treat Rep; 1982 Apr; 66(4):1023-33. PubMed ID: 7074630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary malignant tumors following treatment of Hodgkin's disease].
    Shishkin IP
    Med Radiol (Mosk); 1984 Aug; 29(8):24-8. PubMed ID: 6590941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late complications of Hodgkin's disease management.
    Young RC; Bookman MA; Longo DL
    J Natl Cancer Inst Monogr; 1990; (10):55-60. PubMed ID: 2189477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cancers caused by therapeutic noxae: cancer and radiotherapy].
    Tubiana M
    Bull Cancer; 1983; 70(1):47-54. PubMed ID: 6839034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of second solid cancer in patients after treatment of Hodgkin's disease.
    Glanzmann C; Veraguth A; Lütolf UM
    Strahlenther Onkol; 1994 Mar; 170(3):140-6. PubMed ID: 8160093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.